Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen-Reference-Cited by-同舟云学术

Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen

Published:2019-01-02 Issue:6 Volume:104 Page:1937-1947
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

van Velzen Daan M¹²^ORCID,Paldino Alessia¹³⁴,Klaver Maartje¹,Nota Nienke M¹,Defreyne Justine⁵⁶,Hovingh G Kees⁷,Thijs Abel¹,Simsek Suat¹²,T’Sjoen Guy⁵⁶,den Heijer Martin¹

Affiliation:

1. Division of Endocrinology, Department of Internal Medicine, Amsterdam University Medical Center, De Boelelaan, HV Amsterdam, Netherlands

2. Department of Endocrinology, Northwest Clinics, Wilhelminalaan, JD Alkmaar, Netherlands

3. Cardiothoracic Department, Azienda Sanitaria Universitaria Integrata, Via Giovanni Sai, Trieste, Italy

4. University of Trieste, Trieste, Italy

5. Department of Endocrinology, Ghent University Hospital, Corneel Heymanslaan, Ghent, Belgium

6. Center for Sexology and Gender, Ghent University Hospital, Corneel Heymanslaan, Ghent, Belgium

7. Department of Vascular Medicine, Amsterdam University Medical Center, Meibergdreef DD, Amsterdam, Netherlands

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/6/1937/28462647/jc.2018-02138.pdf

Reference57 articles.

1. European Society of Cardiology: cardiovascular disease statistics 2017;Timmis;Eur Heart J,2018

2. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease;Grodstein;N Engl J Med,1996

3. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study;Bush;JAMA,1983

4. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial;JAMA,1995

5. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial;Rossouw;JAMA,2002

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic and cardiovascular risks of hormone treatment for transgender individuals;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. Association between serum estradiol and cardiovascular health among transgender adults using gender-affirming estrogen therapy;American Journal of Physiology-Heart and Circulatory Physiology;2024-08-01

3. Transgender Women Exhibit a Distinct Stress Echocardiography Profile Compared With Age-Matched Cisgender Counterparts: The Mayo Clinic Women’s Heart Clinic Experience;Journal of the American Society of Echocardiography;2024-08

4. Transgender healthcare: metabolic outcomes and cardiovascular risk;Diabetologia;2024-07-03

5. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans;JAMA Network Open;2024-07-02